Follow
Gregory Lawrence Branigan
Gregory Lawrence Branigan
Verified email at email.arizona.edu
Title
Cited by
Cited by
Year
Statin therapy and risk of Alzheimer's and age‐related neurodegenerative diseases
G Torrandell‐Haro, GL Branigan, F Vitali, N Geifman, JM Zissimopoulos, ...
Alzheimer's & Dementia: Translational Research & Clinical Interventions 6 (1 …, 2020
662020
Association between menopausal hormone therapy and risk of neurodegenerative diseases: Implications for precision hormone therapy
YJ Kim, M Soto, GL Branigan, K Rodgers, RD Brinton
Alzheimer's & Dementia: Translational Research & Clinical Interventions 7 (1 …, 2021
512021
Association between hormone-modulating breast cancer therapies and incidence of neurodegenerative outcomes for women with breast cancer
GL Branigan, M Soto, L Neumayer, K Rodgers, RD Brinton
JAMA network open 3 (3), e201541-e201541, 2020
432020
Association between specific type 2 diabetes therapies and risk of alzheimer’s disease and related dementias in propensity-score matched type 2 diabetic patients
G Torrandell-Haro, GL Branigan, RD Brinton, KE Rodgers
Frontiers in Aging Neuroscience 14, 878304, 2022
92022
Knockdown of epigenetic transcriptional co-regulator Brd2a disrupts apoptosis and proper formation of hindbrain and midbrain-hindbrain boundary (MHB) region in zebrafish
T Murphy, H Melville, E Fradkin, G Bistany, G Branigan, K Olsen, ...
Mechanisms of Development 146, 10-30, 2017
92017
Preventing Alzheimer's disease within reach by 2025: Targeted‐risk‐AD‐prevention (TRAP) strategy
F Vitali, GL Branigan, RD Brinton
Alzheimer's & Dementia: Translational Research & Clinical Interventions 7 (1 …, 2021
72021
Androgen‐targeting therapeutics mitigate the adverse effect of GnRH agonist on the risk of neurodegenerative disease in men treated for prostate cancer
GL Branigan, G Torrandell‐Haro, M Soto, EP Gelmann, F Vitali, ...
Cancer Medicine 11 (13), 2687-2698, 2022
52022
Breast cancer therapies reduce risk of Alzheimer’s disease and promote estrogenic pathways and action in brain
GL Branigan, G Torrandell-Haro, S Chen, Y Shang, S Perez-Miller, Z Mao, ...
Iscience 26 (11), 2023
42023
Breast cancer therapies reduce risk of Alzheimer’s disease and dementia: A claims‐based retrospective study with clinic to bench implications
GL Branigan, G Torrandell‐Haro, RD Brinton
Alzheimer's & Dementia 17, e055602, 2021
32021
Zebrafish Paralogs brd2a and brd2b Are Needed for Proper Circulatory, Excretory and Central Nervous System Formation and Act as Genetic Antagonists during …
GL Branigan, KS Olsen, I Burda, MW Haemmerle, J Ho, A Venuto, ...
Journal of Developmental Biology 9 (4), 46, 2021
32021
Age and sex differences on anti-hyperglycemic medication exposure and risk of newly diagnosed multiple sclerosis in propensity score matched type 2 diabetics
GL Branigan, G Torrandell-Haro, F Vitali, RD Brinton, K Rodgers
Heliyon 8 (10), 2022
22022
Asymptomatic carotid artery stenosis is associated with increased Alzheimer’s disease and non-Alzheimer’s disease dementia risk
F Vitali, G Torrandell-Haro, G Branigan, JA Aristizabal, E Reiman, ...
Stroke and Vascular Neurology, svn-2024-003164, 2024
2024
Syndrome of inappropriate antidiuretic hormone release secondary to central nervous system coccidioidomycosis with vasculitis
GL Branigan, HT Ozgur, J Lim, T Riaz
BMJ Case Reports CP 17 (3), e258915, 2024
2024
Implications for Age and Sex Differences on Anti-Hyperglycemic Therapy Exposure and Incidence of Newly Diagnosed Multiple Sclerosis in Propensity Score Matched Type 2 Diabetics …
G Branigan, GT Haro, F Vitali, R Brinton, K Rodgers
Neurology 100 (17_supplement_2), 1781, 2023
2023
Statin responder analysis for precision prevention of Alzheimer’s Disease
G Torrandell‐Haro, GL Branigan, KE Rodgers, RD Brinton
Alzheimer's & Dementia 18, e068305, 2022
2022
Statin Responder Analysis for Precision Prevention of Neurological Diseases (S15. 010)
GT Haro, G Branigan, K Rodgers, RD Brinton
Neurology 98 (18_supplement), 2944, 2022
2022
Statin therapies reduce risk of Alzheimer’s disease and dementia with increased protective therapeutic effect with increasing age
G Torrandell‐Haro, GL Branigan, F Vitali, RD Brinton
Alzheimer's & Dementia 17, e055735, 2021
2021
Reduction of risk of development of Alzheimer’s disease and related dementias in patients with type 2 diabetes by drugs to treat hyperglycemia
KE Rodgers, G Torrandell‐Haro, GL Branigan, RD Brinton
Alzheimer's & Dementia 17, e055666, 2021
2021
Individual classes of prostate cancer therapies impact risk of Alzheimer’s disease: A claims‐based retrospective study
GL Branigan, G Torrandell‐Haro, RD Brinton
Alzheimer's & Dementia 17, e055615, 2021
2021
Alzheimer’s disease prevention: Within reach by 2025
F Vitali, GL Branigan, RD Brinton
Alzheimer's & Dementia 17, e055621, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–20